PURPOSE: In an effort to study the importance of stromal involvement in angiogenesis, we developed a novel, multicellular model that utilizes three of the primary cell types involved in tumor angiogenesis. METHODS: Fluorescently labeled human microvascular endothelial cells (HMVECs), 10T1/2 cells and myofibroblasts were incubated in the presence of a three-dimensional tumor cell cluster resuspended in collagen and embedded in Matrigel. RESULTS: HMVECs cultured in the presence of a human SKOV-3 ovarian carcinoma tumor cell cluster, surrounded the tumor cell cluster, while myofibroblasts invaded the cluster, localizing within the tumor cell mass. In contrast, 10T1/2 cells, a pluripotent mouse mesenchymal cell line with pericyte-like properties, did not demonstrate the same invasive phenotype. HMVECs cultured in the presence of myofibroblasts invaded the tumor cell cluster and colocalized with the myofibroblasts as demonstrated by fluorescent microscopy and immunohistochemistry. The angiogenesis inhibitors SU6668 and paclitaxel inhibited stromal invasion, while a broad-spectrum matrix metalloproteinase inhibitor did not. CONCLUSIONS: This model emphasizes the critical interaction between endothelial cells and myofibroblasts and provides a more complete in vitro model for studying angiogenesis and tumor progression.
PURPOSE: In an effort to study the importance of stromal involvement in angiogenesis, we developed a novel, multicellular model that utilizes three of the primary cell types involved in tumor angiogenesis. METHODS: Fluorescently labeled human microvascular endothelial cells (HMVECs), 10T1/2 cells and myofibroblasts were incubated in the presence of a three-dimensional tumor cell cluster resuspended in collagen and embedded in Matrigel. RESULTS: HMVECs cultured in the presence of a humanSKOV-3 ovarian carcinoma tumor cell cluster, surrounded the tumor cell cluster, while myofibroblasts invaded the cluster, localizing within the tumor cell mass. In contrast, 10T1/2 cells, a pluripotent mouse mesenchymal cell line with pericyte-like properties, did not demonstrate the same invasive phenotype. HMVECs cultured in the presence of myofibroblasts invaded the tumor cell cluster and colocalized with the myofibroblasts as demonstrated by fluorescent microscopy and immunohistochemistry. The angiogenesis inhibitors SU6668 and paclitaxel inhibited stromal invasion, while a broad-spectrum matrix metalloproteinase inhibitor did not. CONCLUSIONS: This model emphasizes the critical interaction between endothelial cells and myofibroblasts and provides a more complete in vitro model for studying angiogenesis and tumor progression.
Authors: Seema M Ehsan; Katrina M Welch-Reardon; Marian L Waterman; Christopher C W Hughes; Steven C George Journal: Integr Biol (Camb) Date: 2014-06 Impact factor: 2.192
Authors: Ana P D Demasi; Carolina A B Silva; Alessandra D Silva; Cristiane Furuse; Andresa B Soares; Albina Altemani; Marcelo H Napimoga; Vera C Araújo Journal: Head Neck Pathol Date: 2011-09-25
Authors: Yael Haberman; Phillip Minar; Rebekah Karns; Phillip J Dexheimer; Sudhir Ghandikota; Samuel Tegge; Daniel Shapiro; Brianne Shuler; Suresh Venkateswaran; Tzipi Braun; Allison Ta; Thomas D Walters; Robert N Baldassano; Joshua D Noe; Joel Rosh; James Markowitz; Jennifer L Dotson; David R Mack; Richard Kellermayer; Anne M Griffiths; Melvin B Heyman; Susan S Baker; Dedrick Moulton; Ashish S Patel; Ajay S Gulati; Steven J Steiner; Neal LeLeiko; Anthony Otley; Maria Oliva-Hemker; David Ziring; Ranjana Gokhale; Sandra Kim; Stephen L Guthery; Stanley A Cohen; Scott Snapper; Bruce J Aronow; Michael Stephens; Greg Gibson; Jonathan R Dillman; Marla Dubinsky; Jeffrey S Hyams; Subra Kugathasan; Anil G Jegga; Lee A Denson Journal: J Crohns Colitis Date: 2020-08-08 Impact factor: 9.071
Authors: Christopher S Szot; Cara F Buchanan; Joseph W Freeman; Marissa Nichole Rylander Journal: Tissue Eng Part C Methods Date: 2013-04-26 Impact factor: 3.056
Authors: Pedro Correa de Sampaio; David Auslaender; Davia Krubasik; Antonio Virgilio Failla; Jeremy N Skepper; Gillian Murphy; William R English Journal: PLoS One Date: 2012-02-20 Impact factor: 3.240